Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel methods of cancer diagnosis and therapy targeted against a cancer stem line

a cancer stem line and cancer technology, applied in the field of cancer diagnosis and treatment, can solve the problems of high proliferative targets, clinical relapse, and increased tumor cell burden, and achieve the effects of clinical relapse, and reducing tumor cell burden

Inactive Publication Date: 2007-02-22
BERGSTEIN IVAN
View PDF32 Cites 76 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides novel methods for treating and detecting cancer by targeting a slow-growing, mutationally-spared cancer stem line that gives rise to highly proliferative mutant cancer cells. The cancer stem line is derived from normal stem cells and is responsible for fueling tumor immortality. The methods include specific cytotoxic targeting, induction of permanent switch, and induction of permanent terminal differentiation and / or apoptosis of the cancer stem line. These methods may lead to a true cancer cure by eradicate the cancer stem line and alleviate clinical relapse. The invention also provides novel methods of cancer diagnosis by early detection of cancer stem lines."

Problems solved by technology

Moreover, this deficiency by conventional models explains many of the inadequacies of treatment regimens derived thereof, e.g., conventional chemotherapies, irradiation, experimental immunotherapies, as well as newer gene-directed therapies designed for treatment of cancer.
However, a problem associated with such treatments is that the targeted highly proliferative mutant cancer cells are largely mortal while their immortal progenitor, i.e., the cancer stem line, will remain spared of such therapies.
This is disadvantageous as the cancer stem line over time can rear more highly proliferative mutant cancer cells, thereby effecting an increase in tumor cell burden and clinical relapse.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
  • Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
  • Novel methods of cancer diagnosis and therapy targeted against a cancer stem line

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0122] A patient is found to have breast cancer by conventional detection techniques (e.g., mammogram and biopsy). Monoclonal antibodies designed to bind specific antigens present on the surfaces of normal mammary gland epithelial stem cells, also possessing an attached therapeutic moiety (e.g., cytotoxin), are delivered intravenously to the patient. This therapeutic monoclonal antibody will seek out and destroy a cancer stem line fueling the breast tumor while largely sparing environmentally-sequestered normal mammary epithelial stem cells (see FIG. 3A). Efforts td limit this toxicity further are discussed in the final section, (III).

II. Forcing a Cancer Stem Line to Undergo Asymmetric Mitosis

[0123] An alternative tactic to immunotherapy for containing a cancer stem line is to design therapies which (rather than killing stem cells) bring about the conditions of a normally sequestered stem cell micro-environment to wayward stem cells (i.e. cancer cells) which in turn should force...

example 2

[0193] A patient is found to have pancreatic cancer by conventional detection techniques (e.g., CT scan and biopsy). A ribozyme is constructed that specifically blocks a factor (e.g., GSK-3-beta) that normally inhibits asymmetric mitosis in pancreatic epithelial stem cells. The ribozyme is placed within a viral vector and delivered intravenously to the patient. This therapeutic vector will force stem cells of pancreatic origin to divide asymmetrically thus causing the cancer stem line fueling the pancreatic tumor to assume arithmetic growth kinetics (see FIG. 3B) without significant toxicity to normal pancreatic epithelial stem cells that are dividing asymmetrically anyway.

[0194] 3) Induction Of Irreversible Stem Line Differentiation

[0195] As mentioned, one novel OSES-derived method of treating cancer (as described in subsection 2) is to force a cancer stem line to switch from symmetric to asymmetric mitotic division. However, in designing such a therapy, it should be remembered t...

example 3

[0206] A patient is found to have lung cancer by conventional detection techniques (e.g., CT scan and biopsy). A ribozyme is constructed that specifically blocks a factor (e.g., SNRPN) that normally activates asymmetric mitosis in lung epithelial stem cells. The ribozyme is placed within a viral vector and delivered intravenously to the patient. This therapeutic vector will force stem cells of lung origin to divide symmetrically thus causing the cancer stem line fueling the lung tumor to assume exponential growth kinetics. This maneuver is quickly followed by intravenous administration of a starvation-inducing agent e.g., inhibitor of nucleic acid synthesis) which forces the cancer stem line to initiate its differentiation program but in a symmetric manner thereby extinguishing the stem line (see FIG. 3C). Toxicity to normal stem cells may be minimal due to their environmental sequestration. Efforts to limit this toxicity further are discussed in the next section (III.).

[0207] III....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
body weightaaaaaaaaaa
Login to View More

Abstract

Improved methods for treatment of cancer which involve the targeting of slow-growing, relatively mutationally-spared cancer stem line are provided. These methods are an improvement over previous cancer therapeutic methods because they provide for very early cancer treatment and reduce the likelihood of clinical relapse after treatment.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation-in-part of U.S. Ser. No. 08 / 933,330, filed Sep. 18, 1997, incorporated by reference in its entirety herein.FIELD OF THE INVENTION [0002] The present invention relates to novel methods for the diagnosis and treatment of cancer, and is based on the novel OSES (“one-step epigenetic switch”) model of carcinogenesis. BACKGROUND OF THE INVENTION [0003] Classical cancer models to date which have attempted to explain the character of cancer cells have typically described them as fast-growing and highly mutant cells. These cancer cells are hypothesized to have been produced during carcinogenesis because of a multi-step neo-Darwinian evolutionary process involving mutation-selection events at the cellular level (Fearon et al, “A Genetic Model for Colorectal Tumorigenesis”, Cell, 61:759-767 (1990); Nowell, “The Clonal Evolution of Tumor Cell Populations”, Science (Washington, D.C.), 194:23-28 (1976)). [0004] Rela...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/395G01N33/50G01N33/574
CPCC07K16/30G01N33/5017G01N33/574A61K31/7088A61K39/39558A61K45/06A61K2039/505C07K2317/77A61P31/00A61P35/00
Inventor BERGSTEIN, IVAN
Owner BERGSTEIN IVAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com